In 2014, the European Respiratory Society published a statement on nutritional assessment
and therapy in COPD. Since then, increasing research has been performed on the role of …

Skeletal muscle dysfunction occurs in patients with chronic obstructive pulmonary disease
(COPD) and affects both ventilatory and nonventilatory muscle groups. It represents a very …

Rationale: Deep learning is a powerful tool that may allow for improved outcome prediction.
Objectives: To determine if deep learning, specifically convolutional neural network (CNN) …

We defined respiratory sarcopenia as a coexistence of respiratory muscle weakness and
decreased respiratory muscle mass. Although respiratory muscle function is indispensable …

Rationale: Loss of skeletal muscle mass and physical inactivity are important manifestations
of chronic obstructive pulmonary disease (COPD), and both are closely related to poor …

The Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) study,
which began in 2007, is an ongoing multicenter observational cohort study of more than …

Background Sarcopenia can contribute to negative outcomes in patients with various lung
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …

Cachexia and muscle wasting are well recognized as common and partly reversible features
of chronic obstructive pulmonary disease (COPD), adversely affecting disease progression …

Background Low-dose chest CT screening is recommended for smokers with the potential
for lung function abnormality, but its role in predicting lung function remains unclear …

Change in body composition with skeletal muscle wasting, a major component of pulmonary
cachexia, is associated with mortality in chronic obstructive pulmonary disease and cancer …